MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
3.130
-0.080
-2.49%
After Hours: 2.439 -0.691 -22.09% 19:56 11/14 EST
OPEN
3.210
PREV CLOSE
3.210
HIGH
3.210
LOW
3.052
VOLUME
129.38K
TURNOVER
--
52 WEEK HIGH
6.31
52 WEEK LOW
1.880
MARKET CAP
154.93M
P/E (TTM)
-2.5559
1D
5D
1M
3M
1Y
5Y
1D
Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates
NASDAQ · 3h ago
Akoya Biosciences reports Q3 EPS (21c), consensus (20c)
TipRanks · 4h ago
Akoya Biosciences lowers FY24 revenue view to $80M-$85M, consensus $98.19M
TipRanks · 4h ago
*Akoya Biosciences Cuts FY24 View To Rev $80M-$85M >AKYA
Dow Jones · 4h ago
*Akoya Biosciences Cites Persistent Macro Challenges >AKYA
Dow Jones · 4h ago
AKOYA BIOSCIENCES INC <AKYA.O> Q3 SHR VIEW $-0.20 -- LSEG IBES DATA
Reuters · 5h ago
AKOYA BIOSCIENCES INC <AKYA.O> FY2024 REV VIEW $98.2 MLN -- LSEG IBES DATA
Reuters · 5h ago
AKOYA BIOSCIENCES Q3 REVENUE USD 18.8 MILLION VS. IBES ESTIMATE USD 25.4 MILLION
Reuters · 5h ago
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.